These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

451 related items for PubMed ID: 37500817

  • 1. Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjögren's syndrome: a systematic review of individual patient data.
    Prasad CB, Kopp CR, Naidu G, Sharma V, Misra DP, Agarwal V, Sharma A.
    Rheumatol Int; 2023 Jul 27. PubMed ID: 37500817
    [Abstract] [Full Text] [Related]

  • 2. Overlap syndrome of anti-aquaporin-4 positive neuromyelitis optica spectrum disorder and systemic lupus erythematosus: A systematic review of individual patient data.
    Kopp CR, Prasad CB, Naidu S, Sharma V, Misra DP, Agarwal V, Sharma A.
    Lupus; 2023 Sep 27; 32(10):1164-1172. PubMed ID: 37487596
    [Abstract] [Full Text] [Related]

  • 3. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R, Roy D, León-Ruiz M, Das S, Dubey S, Benito-León J.
    Qatar Med J; 2022 Sep 27; 2022(3):29. PubMed ID: 35864917
    [Abstract] [Full Text] [Related]

  • 4. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder and systemic autoimmune diseases overlap syndrome: a single-center experience.
    Martín-Nares E, Hernandez-Molina G, Fragoso-Loyo H.
    Lupus; 2019 Oct 27; 28(11):1302-1311. PubMed ID: 31566079
    [Abstract] [Full Text] [Related]

  • 5. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS).
    J Neuroinflammation; 2016 Sep 27; 13(1):280. PubMed ID: 27793206
    [Abstract] [Full Text] [Related]

  • 6. A Case of Primary Sjögren's Syndrome Presenting as Mass-Like Encephalitis, With Progression to Neuromyelitis Optica Spectrum Disorder.
    Lee HJ, Chang SH, Kang EH, Lee YJ, Song YW, Ha YJ.
    Arch Rheumatol; 2017 Dec 27; 32(4):353-357. PubMed ID: 29901009
    [Abstract] [Full Text] [Related]

  • 7. Clinical and radiological profile of neuromyelitis optica spectrum disorders in a Pakistani cohort.
    Rajput HM, Hassan M, Badshah M.
    Mult Scler Relat Disord; 2023 Jun 27; 74():104656. PubMed ID: 37068371
    [Abstract] [Full Text] [Related]

  • 8. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.
    Anamnart C, Tisavipat N, Owattanapanich W, Apiwattanakul M, Savangned P, Prayoonwiwat N, Siritho S, Rattanathamsakul N, Jitprapaikulsan J.
    Mult Scler Relat Disord; 2022 Feb 27; 58():103414. PubMed ID: 35216789
    [Abstract] [Full Text] [Related]

  • 9. The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China.
    Huang W, Tan H, Xia J, Li W, Li X, ZhangBao J, Chang X, Wang L, Wang M, Zhao C, Lu J, Lu C, Dong Q, Zhou L, Quan C, Pan-Yangtze River Delta Alliance for Demyelinating Disease.
    Mult Scler Relat Disord; 2022 Oct 27; 66():104023. PubMed ID: 35843144
    [Abstract] [Full Text] [Related]

  • 10. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ.
    JAMA Neurol; 2015 Jan 27; 72(1):81-7. PubMed ID: 25384099
    [Abstract] [Full Text] [Related]

  • 11. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
    Lana-Peixoto MA, Talim NC, Callegaro D, Marques VD, Damasceno A, Becker J, Gonçalves MVM, Sato H, Brazilian Committee for Treatment and Research in Multiple Sclerosis.
    Mult Scler Relat Disord; 2023 Jul 27; 75():104730. PubMed ID: 37156036
    [Abstract] [Full Text] [Related]

  • 12. Pediatric Neuromyelitis Optica Spectrum Disorder.
    Poisson K, Moeller K, Fisher KS.
    Semin Pediatr Neurol; 2023 Jul 27; 46():101051. PubMed ID: 37451749
    [Abstract] [Full Text] [Related]

  • 13. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
    Topuzova MP, Bisaga GN, Alekseeva TM, Isabekova PS, Сhaykovskaya AD, Panina EB, Pavlova TA, Ternovykh IK.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020 Jul 27; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
    [Abstract] [Full Text] [Related]

  • 14. The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
    Qiao L, Wang Q, Fei Y, Zhang W, Xu Y, Zhang Y, Zhao Y, Zeng X, Zhang F.
    Medicine (Baltimore); 2015 Jul 27; 94(28):e1145. PubMed ID: 26181553
    [Abstract] [Full Text] [Related]

  • 15. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS).
    J Neuroinflammation; 2016 Nov 01; 13(1):281. PubMed ID: 27802825
    [Abstract] [Full Text] [Related]

  • 16. Advances in the long-term treatment of neuromyelitis optica spectrum disorder.
    Anderson M, Levy M.
    J Cent Nerv Syst Dis; 2024 Nov 01; 16():11795735241231094. PubMed ID: 38312734
    [Abstract] [Full Text] [Related]

  • 17. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
    Rempe T, Tarhan B, Rodriguez E, Viswanathan VT, Gyang TV, Carlson A, Tuna IS, Rees J.
    Mult Scler Relat Disord; 2021 Feb 01; 48():102718. PubMed ID: 33388560
    [Abstract] [Full Text] [Related]

  • 18. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
    Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M, in cooperation with the Neuromyelitis Optica Study Group (NEMOS).
    J Neuroinflammation; 2016 Sep 26; 13(1):279. PubMed ID: 27788675
    [Abstract] [Full Text] [Related]

  • 19. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W, Weihua Z, Xiaotun R, Jiuwei L, Xinying Y, Junlan L, Changhong D, Chunhong C, Haitao R, Liying C, Fang F.
    Zhonghua Er Ke Za Zhi; 2015 Apr 26; 53(4):268-73. PubMed ID: 26182501
    [Abstract] [Full Text] [Related]

  • 20. Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort.
    Castro-Suarez S, Guevara-Silva E, Osorio-Marcatinco V, Alvarez-Toledo K, Meza-Vega M, Caparó-Zamalloa C.
    Mult Scler Relat Disord; 2022 Aug 26; 64():103919. PubMed ID: 35691236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.